410 IAC 1-2.5-75 Reporting requirements for physicians and hospital administrators

Sec. 75. (a) It shall be the duty of each: (1) physician licensed under IC 25-22.5; and (2) administrator of a hospital licensed under IC 16-21, or the administrator's representative; to report all cases and suspected cases of the diseases listed in subsection (d). Reporting of specimen results by a laboratory to health officials does not nullify the physician's or administrator's obligations to report the case. (b) Except for HIV infection/disease, the report required by subsection (a) shall be made to the local health officer in whose jurisdiction the patient normally resides or, in the absence of such information, in whose jurisdiction the patient was examined at the time the diagnosis was made or suspected. If the patient is a resident of a different jurisdiction, the local health jurisdiction receiving the report shall forward the report to the local health jurisdiction where the patient resides. If the patient is not a resident of Indiana, the report shall be forwarded to the department. If a person who is required to report is unable to make a report to the local health officer within the time mandated by this rule, a report shall be made directly to the department within the time mandated by this rule. The report for HIV infection/disease shall be made directly to the department in accordance with IC 16-41-2-3. (c) Any reports of diseases required by subsection (a) shall include the following: (1) The patient's: (A) full name; (B) street address; (C) city; (D) zip code; (E) county of residence; (F) telephone number; (G) date of birth or age if date of birth is not available; (H) sex; and (I) race and ethnicity, if available. (2) The date of onset. (3) The diagnosis. (4) Definitive diagnostic test results, for example: (A) culture; (B) IgM; (C) liver enzyme levels; (D) serology; (E) Western blot; (F) interferon gamma release assay; (G) NAAT; or (H) tuberculin skin test. (5) The: (A) name; (B) address; and (C) telephone number; of the attending physician. (6) Other epidemiologically necessary information requested by the: (A) local health officer; (B) state designated districts; or (C) commissioner. (7) Persons who are tested anonymously at a counseling and testing site cannot be reported using personal identifiers. Rather, they are to be reported using a numeric identifier code. The following shall also be reported: (A) Age. (B) Race. (C) Sex. (D) Risk factors. (E) County of residence. (8) The: (A) name; (B) address; and (C) telephone number; of the person completing report. (d) The dangerous communicable diseases and conditions described in this subsection shall be reported within the time specified. Diseases or conditions that are to be reported immediately shall be reported by telephone or other instantaneous means of communication on first knowledge or suspicion of the diagnosis. Diseases that are to be reported within twenty-four (24) hours, seventy-two (72) hours, or five (5) business days shall be reported within twenty-four (24) hours, seventy-two (72) hours, or five (5) business days of first knowledge or suspicion of the diagnosis by telephone, electronic data transfer, other confidential means of communication, or official report forms furnished by the department. During evening, weekend, and holiday hours, those required to report to the local health department should report diseases required to be immediately reported to the after-hours duty officer at the local health department. HIV infection/disease required to be reported to the department during evening, weekend, and holiday hours should be reported immediately to the after-hours duty officer at the department at (317) 233-1325. If unable to contact the after-hours duty officer locally, or one has not been designated locally, those required to report shall file their reports with the after-hours duty officer at the department at (317) 233-1325. DANGEROUS COMMUNICABLE DISEASES AND CONDITIONS Disease When to Report (from probable diagnosis) Disease Intervention Methods (section of this rule) Acquired immunodeficiency syndrome See HIV Infection/Disease Sec. 109 Anaplasmosis Within 72 hours Sec. 96 Animal bites Within 24 hours Sec. 80 Anthrax Immediately Sec. 81 Arboviral disease (non-neuroinvasive or neuroinvasive) (including, but not limited to, dengue, chikungunya, EEE, Japanese encephalitis, La Crosse/California serogroup viruses, Powassan, SLE, WEE, and West Nile virus) Immediately Sec. 82 Babesiosis Within 72 hours Sec. 83 Botulism Immediately Sec. 84 Brucellosis Immediately Sec. 85 Campylobacteriosis Within 72 hours Sec. 86 Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) Within 72 hours Sec. 87 Chancroid Within 72 hours Sec. 88 Chikungunya virus Immediately Sec. 82 Chlamydia trachomatis, genital infection Within 72 hours Sec. 89 Cholera Immediately Sec. 90 Coccidioidomycosis Within 72 hours Sec. 91 Cryptosporidiosis Within 72 hours Sec. 92 Cyclosporiasis Within 72 hours Sec. 93 Cysticercosis (Neurocysticercosis) Within 72 hours Sec. 94 Diphtheria Immediately Sec. 95 Dengue Immediately Sec. 82 Eastern equine encephalitis (EEE) Immediately Sec. 82 Ehrlichiosis Within 72 hours Sec. 96 Escherichia coli (E. coli) infection (Shiga toxin-producing (STEC)), including, but not limited to, E. coli 0157, E. coli 0157:H7, non-0157 E. coli, and Shiga toxin detected Immediately Sec. 97 Giardiasis Within 72 hours Sec. 98 Gonorrhea Within 72 hours Sec. 99 Granuloma inguinale Within 72 hours Sec. 100 Haemophilus influenzae invasive disease, and antimicrobial susceptibility testing* Within 24 hours Sec. 101 Hansen's disease (leprosy) Within 72 hours Sec. 102 Hantavirus pulmonary syndrome Immediately Sec. 103 Hemolytic uremic syndrome, postdiarrheal Immediately Sec. 97 Hepatitis, viral, type A Immediately Sec. 104 Hepatitis, viral, type B Within 72 hours Sec. 105 Hepatitis, viral, type B, pregnant woman (acute and chronic), or perinatally exposed infant Immediately (when discovered at or close to time of birth) Sec. 105 Hepatitis, viral, type C (acute) Within five (5) business days Sec. 106 Hepatitis, viral, type delta Within 72 hours Sec. 105 Hepatitis, viral, type E Immediately Sec. 107 Hepatitis, viral, unspecified Within 72 hours Histoplasma capsulatum Within 72 hours Sec. 108 HIV infection/disease Within 72 hours after informing patient or if patient does not return for test results Sec. 109 HIV infection/disease, pregnant woman, or perinatally exposed infant Immediately (when discovered at or close to time of birth) Sec. 109 Influenza-associated death Within 72 hours Sec. 110 Japanese encephalitis Immediately Sec. 82 La Crosse encephalitis (California serogroup viruses) Immediately Sec. 82 Latent tuberculosis infection Within five (5) business days Sec. 111 Legionellosis Within 72 hours Sec. 112 Leptospirosis Within 72 hours Sec. 113 Listeriosis Within 72 hours Sec. 114 Lyme disease Within 72 hours Sec. 115 Lymphogranuloma venereum Within 72 hours Sec. 116 Malaria Within 72 hours Sec. 117 Measles (rubeola) Immediately Sec. 118 Meningococcal, invasive disease Immediately Sec. 119 Mumps Within 24 hours Sec. 120 Novel influenza A Within 24 hours Sec. 121 Pertussis Within 24 hours Sec. 122 Plague Immediately Sec. 123 Poliomyelitis Immediately Sec. 124 Powassan Immediately Sec. 82 Psittacosis Within 72 hours Sec. 125 Q fever Immediately Sec. 126 Rabies in humans or animals (confirmed and suspect animal with human exposure) Immediately Sec. 127 Rabies, postexposure treatment Within 72 hours Secs. 127 and 80 Rocky Mountain spotted fever Within 72 hours Sec. 128 Rubella (German measles) Immediately Sec. 129 Rubella congenital syndrome Immediately Sec. 129 Salmonellosis, nontyphoidal Within 72 hours Sec. 130 Salmonellosis and antimicrobial susceptibility testing* Within 72 hours Sec. 130 Shigellosis and antimicrobial susceptibility testing* Immediately Sec. 131 Smallpox (variola infection) Immediately Sec. 132 Adverse events or complications due to smallpox vaccination (vaccinia virus infection) or secondary transmission to others after vaccination. This includes accidental implantation at sites other than the vaccination site, secondary bacterial infections at vaccination site, vaccinia keratitis, eczema vaccinatum, generalized vaccinia, congenital vaccinia, progressive vaccinia, vaccinia encephalitis, death due to vaccinia complications, and other complications requiring significant medical intervention. Immediately Sec. 132 St. Louis encephalitis (SLE) Immediately Sec. 82 Staphylococcus aureus, vancomycin resistance level of MIC > 8 μg/mL, or severe Staphylococcus aureus in a previously healthy person Within 72 hours Sec. 133 Streptococcus pneumoniae, invasive disease and antimicrobial susceptibility testing* Within 72 hours Sec. 134 Streptococcus, group A, invasive disease Within 72 hours Sec. 135 Syphilis Within 72 hours Sec. 136 Taenia solium infection Within 72 hours Sec. 137 Tetanus Within 72 hours Sec. 138 Toxic shock syndrome (streptococcal or staphylococcal) Within 72 hours Sec. 139 Trichinosis Within 72 hours Sec. 140 Tuberculosis disease, cases and suspects Within 24 hours Sec. 141 Tularemia Immediately Sec. 142 Typhoid and paratyphoid fever, cases and carriers, and antimicrobial susceptibility testing* Immediately Sec. 143 Typhus, endemic (fleaborne) Within 72 hours Sec. 144 Varicella (chickenpox) Within 72 hours Sec. 145 Vibriosis (non-cholera) Within 72 hours Sec. 146 West Nile virus (WNV) Immediately Sec. 82 Western equine encephalitis (WEE) Immediately Sec. 82 Yellow fever Immediately Sec. 147 Yersiniosis Within 72 hours Sec. 148 *Reporting of disease is required to follow the "When to Report (from probable diagnosis)" time frame, and the antimicrobial susceptibility testing results are to be reported as soon as they become available. (e) Reporting of HIV infection/disease shall include classification as defined in the CDC Morbidity and Mortality Weekly Report Volume 63, No. RR-03, April 11, 2014. Supplemental reports shall be provided by the physician when an individual's classification changes. The CD4+ T-lymphocyte count and percentage or viral load count, or both, shall be included with both initial and supplemental reports. (f) The department, under the authority of IC 4-22-2-37.1, may adopt emergency rules to include mandatory reporting of emerging infectious diseases. Reports shall include the information specified in subsection (c). (g) Outbreaks of any of the following shall be reported immediately upon suspicion: (1) Any disease required to be reported under this section. (2) Diarrhea of the newborn (in hospitals or other institutions). (3) Foodborne or waterborne diseases in addition to those specified by name in this rule. (4) Streptococcal illnesses. (5) Conjunctivitis. (6) Impetigo. (7) Nosocomial disease within hospitals and health care facilities. (8) Influenza-like illness. (9) Viral meningitis. (10) Unusual occurrence of disease. (11) Any disease, including, but not limited to: (A) anthrax; (B) plague; (C) tularemia; (D) Brucella species; (E) smallpox; (F) botulism; or (G) multiple drug-resistant tuberculosis. (12) Chemical illness that is considered: (A) a bioterrorism threat; (B) an importation; or (C) a laboratory release. (h) Failure to report constitutes a Class A infraction as specified by IC 16-41-2-8.